TELA Bio reported a quarterly loss of $0.16 per share versus the Zacks consensus loss of $0.18, beating estimates by $0.02. The loss improved from $0.23 a year ago, a $0.07 year-over-year improvement. The print is a modest upside to expectations and could be a modest positive catalyst for the stock.
TELA Bio reported a quarterly loss of $0.16 per share versus the Zacks consensus loss of $0.18, beating estimates by $0.02. The loss improved from $0.23 a year ago, a $0.07 year-over-year improvement. The print is a modest upside to expectations and could be a modest positive catalyst for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.12
Ticker Sentiment
